Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
While Ozempic has the potential to cause rapid weight loss initially, it is not intended as a quick fix
PMID: 40544433) is potentially the most impactful obesity trial since the original STEP and SURMOUNT programs
You can take Ozempic with or without food
Hear from the 210+ people whove shared their experiences so far Two Convenient San Antonio Locations Central Airport Location Northwest La Cantera Location Get the real scoop on pelvic health (finally!) Subscribe to our weekly newsletter The Weekly Squeeze where we cover everything your doctor didnt, from healing timelines to Kegel conspiracy theories
Table of Contents What Is Retatrutide and Its Current Development Status in the UK Risks of Sourcing Unregulated Peptides Online MHRA Guidance on Unlicensed Weight Loss Treatments Approved Alternatives Available Through NHS and Private Clinics How to Speak to a UK Doctor About Emerging Weight Loss Options Scientific References Frequently Asked Questions What Is Retatrutide and Its Current Development Status in the UK Retatrutide is an investigational triple incretin receptor agonist (GLP-1, GIP, and glucagon) developed by Eli Lilly that remains in Phase 3 trials and holds no MHRA marketing authorisation as of mid-2025
